Alternate nostril breathing versus Buteyko breathing for improving asthma symptoms

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will randomize 40 adults (age 18–45) with mild-to-moderate persistent bronchial asthma to receive either Alternate Nostril Breathing or the Buteyko Breathing Technique in addition to their usual medications. Interventions last four weeks with two supervised sessions per week plus guided home practice, and outcomes include control pause, dyspnea scores, spirometry measures, and asthma control. The trial excludes patients with acute exacerbations, acute infections, inability to follow instructions, or a control pause greater than 40 seconds. Group differences in symptom scores and pulmonary function will be compared to see which breathing technique produces greater short-term improvements.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age between 18-45 years
* Both genders (male and female)
* Grade 1-3 on mMRC scale of dyspnea
* Asthma severity classes- intermediate,mild persistent and moderate persistent asthma (acc. to NAEPP National Asthma Education and Prevention Program guidlines 2020)

Exclusion Criteria:

* Patients having acute exerbation of COPD/status asthmaticus
* Patients diagnosed with acute infection
* Patients unable to follow command and instructions
* Asthma patients with \>40sec control pause duration

Where it's running

• Foundation University Islamabad
  Islamabad, Pakistan Recruiting

Study contacts

• Study coordinator: Maryam Arooj, MSPT-CPPT
• Email: maryamarooj418@gmail.com
• Phone: +923428190176

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• IOS-based platform to screen, diagnose, and manage COPD and asthma

  This study tests an Impulse Oscillometry system to screen for and diagnose COPD and asthma and to help predict flare-ups over about a year, involving adults in China.

  Recruiting Beijing Chao Yang Hospital · Beijing, Beijing Municipality · NCT07910409

• REACH: Resources and Education to Help Kids with Asthma in School

  A service model called REACH will try to improve school-based asthma care by coordinating care between healthcare, school, and home for children with asthma.

  Recruiting Washington University School of Medicine · St Louis, Missouri · NCT07819747

• Beclometasone Dipropionate and Formoterol inhalation combo vs FOSTER in adults with asthma

  This Phase 3 trial tests whether a beclometasone formoterol inhalation combo works as well or better than FOSTER for adults with asthma.

  Recruiting Phase 3 Lunan Better Pharmaceutical Co., LTD. · Shanghai, Shanghai Municipality · NCT07768891

• Test of SKB575 in adults with asthma

  This study tests whether SKB575 helps people with asthma compared to a placebo.

  Recruiting at 2 sites Phase 1 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Chengdu, Sichuan and 1 other locations · NCT07732023

• KT-621 long-term safety and efficacy in asthma patients previously in KT-621 study

  This phase 2b study tests KT-621 in people with asthma who finished a prior KT-621 study to see if long-term treatment is safe and helpful.

  Recruiting at 7 sites Phase 2 Kymera Therapeutics, Inc. · Miami, Florida and 6 other locations · NCT07677059

• Dog-allergy immunotherapy with Alutard SQ Dog in Swedish practice

  This study tests whether Alutard SQ Dog immunotherapy helps adults with moderate-to-severe dog allergy when used in real-world Swedish care.

  Recruiting at 2 sites Phase 4 Karolinska Institutet · Lund, Skåne County and 1 other locations · NCT07651891

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.